Suppr超能文献

一种用于识别转移性膀胱癌患者中原发性肿瘤切除最佳患者的模型。

A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.

作者信息

Hu Jintao, Zheng Zhenming, Zheng Junjiong, Xie Weibin, Su Huabin, Yang Jingtian, Xu Zixin, Shen Zefeng, Yu Hao, Fan Xinxiang, Kong Jianqiu, Han Jinli

机构信息

Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Oncol. 2022 Jan 19;11:809664. doi: 10.3389/fonc.2021.809664. eCollection 2021.

Abstract

BACKGROUND

A survival benefit was observed in metastatic bladder cancer patients who underwent primary tumor resection, but it was still confusing which patients are suitable for the surgery. For this purpose, we developed a model to screen stage M1 patients who would benefit from primary tumor resection.

METHODS

Patients with metastatic bladder cancer were screened from the Surveillance, Epidemiology, and End Results database (2004-2016) and then were divided into surgery (partial or complete cystectomy) group and non-surgery group. To balance the characteristics between them, a 1:1 propensity score matching analysis was applied. A hypothesis was proposed that the received primary tumor resection group has a more optimistic prognosis than the other group. The multivariable Cox model was used to explore the independent factors of survival time in two groups (beneficial and non-beneficial groups). Logistic regression was used to build a nomogram based on the significant predictive factors. Finally, a variety of methods are used to evaluate our model.

RESULTS

A total of 7,965 patients with metastatic bladder cancer were included. And 3,314 patients met filtering standards, of which 545 (16.4%) received partial or complete cystectomy. Plots of the Kaplan-Meier and subgroup analyses confirmed our hypothesis. After propensity score matching analysis, a survival benefit was still observed that the surgery group has a longer median overall survival time (11.0 vs. 6.0 months, < 0.001). Among the surgery cohort, 303 (65.8%) patients lived longer than 6 months (beneficial group). Differentiated characteristics included age, gender, TNM stage, histologic type, differentiation grade, and therapy, which were integrated as predictors to build a nomogram. The nomogram showed good discrimination in both training and validation cohorts (area under the receiver operating characteristic curve (AUC): 0.806 and 0.742, respectively), and the calibration curves demonstrated good consistency. Decision curve analysis showed that the nomogram was clinically useful. Compared with TNM staging, our model shows a better predictive value in identifying optimal patients for primary tumor resection.

CONCLUSIONS

A practical predictive model was created and verified, which might be used to identify the optimal candidates for the partial or complete cystectomy group of the primary tumor among metastatic bladder cancer.

摘要

背景

在接受原发性肿瘤切除的转移性膀胱癌患者中观察到了生存获益,但仍不清楚哪些患者适合进行该手术。为此,我们开发了一种模型来筛选能从原发性肿瘤切除中获益的M1期患者。

方法

从监测、流行病学和最终结果数据库(2004 - 2016年)中筛选出转移性膀胱癌患者,然后将其分为手术组(部分或全膀胱切除术)和非手术组。为平衡两组之间的特征,应用了1:1倾向评分匹配分析。提出一个假设,即接受原发性肿瘤切除的组比另一组有更乐观的预后。使用多变量Cox模型探索两组(获益组和非获益组)生存时间的独立因素。基于显著预测因素,采用逻辑回归构建列线图。最后,使用多种方法评估我们的模型。

结果

共纳入7965例转移性膀胱癌患者。其中3314例患者符合筛选标准,其中545例(16.4%)接受了部分或全膀胱切除术。Kaplan - Meier曲线和亚组分析证实了我们的假设。经过倾向评分匹配分析后,仍观察到生存获益,手术组的中位总生存时间更长(11.0个月对6.0个月,<0.001)。在手术队列中,303例(65.8%)患者生存时间超过6个月(获益组)。差异特征包括年龄、性别、TNM分期、组织学类型、分化程度和治疗方式,将这些因素整合为预测指标来构建列线图。该列线图在训练队列和验证队列中均显示出良好的区分度(受试者操作特征曲线下面积(AUC)分别为0.806和0.742),校准曲线显示出良好的一致性。决策曲线分析表明该列线图具有临床实用性。与TNM分期相比,我们的模型在识别原发性肿瘤部分或全膀胱切除术的最佳患者方面显示出更好的预测价值。

结论

创建并验证了一种实用的预测模型,该模型可用于识别转移性膀胱癌中适合原发性肿瘤部分或全膀胱切除术组的最佳候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/8807493/51969219f073/fonc-11-809664-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验